Edward L. Keyes Resident Contest for Outstanding Case Reports
Named in memory of Edward L. Keyes (1843 – 1924), a New York dermatologist who invented the cutaneous punch, known as the Keyes punch.
16th World Congress of the International Academy of Cosmetic Dermatology
June 9-11, 2021
Abstract deadline: March 1, 2021
To be awarded for the best Case Report submitted by a physician in training (resident, fellow, or registrar) for presentation at the 16th World Congress of the International Academy of Cosmetic Dermatology in Xi’an, China June 9-11, 2021.
We invite you to submit original Case Reports that reflect the presentation of new ideas and original observations to the Academy membership and other attendees of the Congress. The case may be medical, surgical, and cosmetic (or combined) in nature.
The author whose abstract receives the highest score during the review process will receive a scholarship by the IACD to present the full paper at the 16th World Congress of the International Academy of Cosmetic Dermatology in Xi’an, China June 9-11, 2021. The scholarship will provide reasonable travel expenses, lodging for 3 nights, the Congress registration fee, and a basic spending stipend.
Please submit your case report abstract via email to Vesna.M.Petronic-Rosic@medstar.net before noon, CDT, March 1, 2021. The abstract should be no longer than 2,500 characters including spacing. Material that was previously presented, published, or submitted for publication should not be offered. Applications will be graded based upon the educational value of the abstract and the extent to which it presents new and significant work. The Review Committee strongly recommends that abstracts have an organized, coherent, well-thought-out, and complete presentation. Please note that no paper submitted for consideration will be eligible if it has already been, or is in consideration for publication elsewhere at any time prior to the meeting. The winner(s) agree to publish their outstanding case report(s) in SKINmed: Dermatology for the Clinician, an official publication of the International Academy of Cosmetic Dermatology. By submitting your paper for consideration, you give SKINmed: Dermatology for the Clinician first-rights of refusal for publication through December 31, 2021. The applicant must be in training at the time of the Congress presentation.
All applicants will receive e-mail notice of the Resident Case Report Review Committee’s decision by March 31, 2021.
Vesna M. Petronic-Rosic, MD, MSc, MBA
Chair, Resident Contest Committee
Chair, Department of Dermatology
MedStar Washington Hospital Center
Tel: +1(302) 455-7546
|Previous Edward L. Keyes Prize paper winner|
|Year||Winner||Title of Winning Paper|
|2018||Hari Darmawan, MD
– Palembang, Indonesia
|Split-face comparative study of microneedling with platelet-rich plasma versus microneedling alone in treating acne scars: A case series|
|2018||Joaquín Felipe Ramirez Oliveros, MD
– Rio de Janeiro, Brazil
|Microneedling with drug delivery (hydroquinone 4% serum) as an adjuvant therapy for recalcitrant melasma|
|2017||Sendrasoa Fandresena, MD
|Pemphigus vulgaris as the first manifestation of multiple myeloma|
|2017||Sushmitha Jayaprasad, MD
– Bangalore, India
|Familial dyskeratotic comedones (FDC): A rare challenging disease|
|2016||Michael Lavery, MD
– Philadelphia, PA, USA
|A case of ischemia induced perianal ulceration|
|2015||Vinay Keshavamurthy, MD
– Chandigarh, India
|Grotesque face secondary to immunotherapy: Cure circumvallating to curse|
|2015||Donald Warren, MD
– Austin, TX, USA
|Facial blanching after cosmetic botulinum toxin injection case series|
|2013||Dominique C. Pichard, MD
– Washington DC, USA
|Zinc deficiency disorders among extremely premature infants|
|2013||Navid Ezra, MD
– Indianapolis, IN
|Localized scleroderma treated with ablative fractional laser therapy and injectable fillers|
|2012||Razvigor Darlenski, MD, PhD
– Sofia, Bulgaria
|Hair extension – novel “source” of a well-known contact allergen|
|2012||Edidiong Kaminska, MD
– Chicago, IL, USA
|Combining field therapies with sequential topical 5-fluorouracil followed by 5-aminolevulinic acid photodynamic therapy for actinic keratoses|